Repository logo

Lesion-specific 3D-printed moulds for image-guided tissue multi-sampling of ovarian tumours: A prospective pilot study

Published version



Change log


Delgado-Ortet, Maria 
Reinius, Marika AV 
McCague, Cathal 
Bura, Vlad 
Woitek, Ramona 


jats:secjats:titleBackground</jats:title>jats:pHigh-Grade Serous Ovarian Carcinoma (HGSOC) is the most prevalent and lethal subtype of ovarian cancer, but has a paucity of clinically-actionable biomarkers due to high degrees of multi-level heterogeneity. Radiogenomics markers have the potential to improve prediction of patient outcome and treatment response, but require accurate multimodal spatial registration between radiological imaging and histopathological tissue samples. Previously published co-registration work has not taken into account the anatomical, biological and clinical diversity of ovarian tumours.</jats:p></jats:sec>jats:secjats:titleMethods</jats:title>jats:pIn this work, we developed a research pathway and an automated computational pipeline to produce lesion-specific three-dimensional (3D) printed moulds based on preoperative cross-sectional CT or MRI of pelvic lesions. Moulds were designed to allow tumour slicing in the anatomical axial plane to facilitate detailed spatial correlation of imaging and tissue-derived data. Code and design adaptations were made following each pilot case through an iterative refinement process.</jats:p></jats:sec>jats:secjats:titleResults</jats:title>jats:pFive patients with confirmed or suspected HGSOC who underwent debulking surgery between April and December 2021 were included in this prospective study. Tumour moulds were designed and 3D-printed for seven pelvic lesions, covering a range of tumour volumes (7 to 133 cmjats:sup3</jats:sup>) and compositions (cystic and solid proportions). The pilot cases informed innovations to improve specimen and subsequent slice orientation, through the use of 3D-printed tumour replicas and incorporation of a slice orientation slit in the mould design, respectively. The overall research pathway was compatible with implementation within the clinically determined timeframe and treatment pathway for each case, involving multidisciplinary clinical professionals from Radiology, Surgery, Oncology and Histopathology Departments.</jats:p></jats:sec>jats:secjats:titleConclusions</jats:title>jats:pWe developed and refined a computational pipeline that can model lesion-specific 3D-printed moulds from preoperative imaging for a variety of pelvic tumours. This framework can be used to guide comprehensive multi-sampling of tumour resection specimens.</jats:p></jats:sec>



Journal Title

Frontiers in Oncology

Conference Name

Journal ISSN


Volume Title


Frontiers Media SA
Cancer Research UK (C197/A28667)
Cancer Research UK (C14303/A17197)
Cancer Research UK (S_4089)
Cancer Research UK (A22905)
Wellcome Trust (215733/Z/19/Z)
National Institute for Health Research (IS-BRC-1215-20014)
W.D. Armstrong Trust Fund, CRUK National Cancer Imaging Translational Accelerator (NCITA) [C42780/A27066], The Mark Foundation for Cancer Research [C9685], the Austrian Science Fund [J-4025], National Institute of Health Research (NIHR) Cambridge Biomedical Research Centre [BRC-1215-20014].